Research statistics
Bivalirudin research: publications and trials
At a glance
Publications, all years
1,710
Since 1991
Publications in 2026 so far
49
Through November 15, 2026
Human clinical research
51.8%
878 of 1,694 classified
Registered clinical trials
69
ClinicalTrials.gov
Randomized controlled trials
260
Publications reporting an RCT in people
Systematic reviews and meta-analyses
109
Preclinical studies
10.1%
74 animal · 85 in vitro · 12 computational
Records that only mention it
530
Not counted above
Status in the library: FDA-approved. 16 publications are not yet classified by study type.
What to keep in mind
- Some completed trials have neither posted results nor a linked results publication.
Publications by year
Bivalirudin publications by year and evidence
Show the data
| Year | Human clinical research | Preclinical (animal, in vitro, computational) | Reviews and meta-analyses | Other and not yet classified | Total |
|---|---|---|---|---|---|
| 1991 | 0 | 3 | 0 | 0 | 3 |
| 1992 | 0 | 5 | 1 | 1 | 7 |
| 1993 | 5 | 3 | 1 | 1 | 10 |
| 1994 | 3 | 4 | 1 | 2 | 10 |
| 1995 | 5 | 3 | 6 | 2 | 16 |
| 1996 | 0 | 8 | 6 | 0 | 14 |
| 1997 | 2 | 6 | 3 | 1 | 12 |
| 1998 | 5 | 6 | 2 | 0 | 13 |
| 1999 | 3 | 2 | 9 | 1 | 15 |
| 2000 | 1 | 1 | 11 | 0 | 13 |
| 2001 | 2 | 1 | 4 | 6 | 13 |
| 2002 | 8 | 3 | 15 | 7 | 33 |
| 2003 | 13 | 7 | 15 | 3 | 38 |
| 2004 | 28 | 4 | 16 | 6 | 54 |
| 2005 | 28 | 3 | 19 | 5 | 55 |
| 2006 | 34 | 3 | 16 | 6 | 59 |
| 2007 | 34 | 8 | 19 | 8 | 69 |
| 2008 | 40 | 2 | 18 | 7 | 67 |
| 2009 | 41 | 6 | 12 | 7 | 66 |
| 2010 | 42 | 3 | 18 | 15 | 78 |
| 2011 | 48 | 5 | 17 | 10 | 80 |
| 2012 | 38 | 8 | 14 | 11 | 71 |
| 2013 | 47 | 6 | 15 | 12 | 80 |
| 2014 | 50 | 10 | 12 | 17 | 89 |
| 2015 | 45 | 5 | 32 | 18 | 100 |
| 2016 | 38 | 5 | 26 | 15 | 84 |
| 2017 | 46 | 6 | 14 | 14 | 80 |
| 2018 | 31 | 3 | 12 | 12 | 58 |
| 2019 | 31 | 2 | 9 | 14 | 56 |
| 2020 | 39 | 8 | 7 | 8 | 62 |
| 2021 | 36 | 8 | 7 | 8 | 59 |
| 2022 | 30 | 5 | 10 | 5 | 50 |
| 2023 | 28 | 4 | 14 | 10 | 56 |
| 2024 | 25 | 2 | 9 | 9 | 45 |
| 2025 | 29 | 6 | 6 | 5 | 46 |
| 2026 (to date) | 23 | 7 | 12 | 7 | 49 |
Study types
| Observational human study | 368 |
|---|---|
| Review | 299 |
| Randomized controlled trial | 260 |
| Editorial, letter or other | 234 |
| Case report | 187 |
| Meta-analysis | 95 |
| In vitro study | 85 |
| Animal study | 74 |
| Other clinical trial | 63 |
| Not yet classified | 16 |
| Systematic review | 14 |
| Computational study | 12 |
| Guideline or consensus | 3 |
Research areas
From MeSH major topics. A paper can be in several areas.
| Cardiovascular | 1,454 |
|---|---|
| Immune system | 85 |
| Tissue repair | 80 |
| Metabolic health | 62 |
| Neurological and mental health | 42 |
| Reproductive and sexual health | 32 |
| Endocrinology | 22 |
| Antimicrobial and infectious disease | 18 |
| Gastrointestinal | 7 |
| Oncology | 7 |
| Dermatology | 4 |
| Longevity and aging | 2 |
Registered clinical trials
9 of 28 trials completed at least a year before the cutoff have neither posted results nor a linked results publication. A registration is not a result.
Completed: 32 · Unknown status: 21 · Terminated: 6 · Recruiting: 5 · Withdrawn: 3 · Active, not recruiting: 1 · Not yet recruiting: 1
Phase not applicable: 11 · Phase 1: 2 · Phase 2: 5 · Phase 3: 22 · Phase 4: 29
The 50 most recently started of 69 trials.
Human trials and evidence reviews
Meta-analyses, systematic reviews and trials in people, newest first.
- Bivalirudin Versus Heparin and Protamine in Adult Patients Undergoing Cardiac Surgery: A Systematic Review and Meta-Analysis.
Annals of cardiac anaesthesia · October 12, 2026 · Meta-analysis · cited 0 times · open access
PMID 42862663 · DOI 10.4103/aca.aca_28_26 · Reviews and meta-analyses
- Comparison of bivalirudin versus heparin in percutaneous coronary intervention for patients with acute coronary syndrome: A meta-analysis.
Medicine · September 1, 2026 · Meta-analysis · cited 0 times · open access
PMID 42798052 · DOI 10.1097/md.0000000000050046 · Reviews and meta-analyses
- Effectiveness and safety of bivalirudin anticoagulation therapy in adult patients receiving extracorporeal membrane oxygenation: A systematic review and meta-analysis.
Medicine · August 1, 2025 · Meta-analysis · cited 3 times · open access
PMID 40826747 · DOI 10.1097/md.0000000000042696 · Reviews and meta-analyses
- Dosing Reliability of Direct Thrombin Inhibitors in Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis.
ASAIO journal (American Society for Artificial Internal Organs : 1992) · July 17, 2025 · Meta-analysis · cited 15 times
PMID 40673548 · DOI 10.1097/mat.0000000000002512 · Reviews and meta-analyses
- Bivalirudin Versus Heparin in Patients Undergoing Percutaneous Coronary Intervention in Acute Coronary Syndromes.
Critical pathways in cardiology · February 21, 2025 · Meta-analysis · cited 2 times
PMID 39133562 · DOI 10.1097/hpc.0000000000000372 · Reviews and meta-analyses
- The efficacy and safety of bivalirudin and heparin in patients with acute coronary syndrome: a systematic review and meta-analysis.
Systematic reviews · February 10, 2025 · Meta-analysis · cited 3 times · open access
PMID 39930484 · DOI 10.1186/s13643-025-02782-7 · Reviews and meta-analyses
- Revisiting the Efficacy and Safety of Bivalirudin in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From a Mixed Treatment Comparison Meta-Analysis of Randomized Trials.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · November 6, 2024 · Meta-analysis · cited 0 times
PMID 39506500 · DOI 10.1002/ccd.31276 · Reviews and meta-analyses
- Bivalirudin vs Heparin Anticoagulation in STEMI: Confirmation of the BRIGHT-4 Results.
Journal of the American College of Cardiology · October 1, 2024 · Meta-analysis · cited 24 times · open access
PMID 39384262 · DOI 10.1016/j.jacc.2024.07.045 · Reviews and meta-analyses
- Bivalirudin Versus Heparin Monotherapy in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Study-level Meta-analysis of Randomized Controlled Trials.
Cardiovascular drugs and therapy · July 30, 2024 · Meta-analysis · cited 3 times
PMID 39080125 · DOI 10.1007/s10557-024-07609-6 · Reviews and meta-analyses
- Differential Use of Glycoprotein IIb/IIIa Inhibitors with Bivalirudin in Patients with STEMI Undergoing PCI: A Systematic Review and Meta-Analysis.
American journal of cardiovascular drugs : drugs, devices, and other interventions · April 29, 2024 · Meta-analysis · cited 1 times
PMID 38683263 · DOI 10.1007/s40256-024-00636-6 · Reviews and meta-analyses
Most cited
By OpenAlex citation count. Citations measure attention, not quality or correctness.
- Bivalirudin during primary PCI in acute myocardial infarction.
The New England journal of medicine · May 1, 2008 · Randomized controlled trial · cited 1,867 times · open access
PMID 18499566 · DOI 10.1056/nejmoa0708191 · Human clinical research
- Bivalirudin for patients with acute coronary syndromes.
The New England journal of medicine · November 1, 2006 · Randomized controlled trial · cited 1,472 times · open access
PMID 17124018 · DOI 10.1056/nejmoa062437 · Human clinical research
- Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial.
JAMA · February 1, 2003 · Randomized controlled trial · cited 1,162 times
PMID 12588269 · DOI 10.1001/jama.289.7.853 · Human clinical research
- Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Chest · February 1, 2012 · Review · cited 1,094 times · open access
PMID 22315264 · DOI 10.1378/chest.11-2291 · Reviews and meta-analyses
- Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial.
Journal of the American College of Cardiology · March 9, 2007 · Randomized controlled trial · cited 799 times · open access
PMID 17394970 · DOI 10.1016/j.jacc.2007.02.027 · Human clinical research
Latest publications
- Bivalirudin With a High-Dose Post-PCI Infusion Versus Heparin During Primary PCI in STEMI: One-Year Results From the BRIGHT-4 Trial.
Circulation. Cardiovascular interventions · October 31, 2026 · Randomized controlled trial · cited 0 times
PMID 42965935 · DOI 10.1161/circinterventions.126.017029 · Human clinical research
- Comprehensive analysis of peptide pharmaceutical: Development of three orthogonal chromatographic methods and characterization of bivalirudin degradation products by high-resolution mass spectrometry.
Journal of pharmaceutical and biomedical analysis · October 12, 2026 · In vitro study · cited 0 times
PMID 42879990 · DOI 10.1016/j.jpba.2026.117761 · In vitro studies
- Bivalirudin Versus Heparin and Protamine in Adult Patients Undergoing Cardiac Surgery: A Systematic Review and Meta-Analysis.
Annals of cardiac anaesthesia · October 12, 2026 · Meta-analysis · cited 0 times · open access
PMID 42862663 · DOI 10.4103/aca.aca_28_26 · Reviews and meta-analyses
- Engineering Immunomodulatory Stents Using a Biomimetic Nanozyme System for Vascular Healing.
Advanced materials (Deerfield Beach, Fla.) · October 5, 2026 · Animal study · cited 0 times · open access
PMID 42830705 · DOI 10.1002/adma.75212 · Animal studies
- Known Unknowns: Unpacking Controversies and Uncertainties in the 2025 Guidelines for Management of Acute Coronary Syndromes.
Current cardiology reports · October 5, 2026 · Review · cited 0 times
PMID 42832065 · DOI 10.1007/s11886-026-02427-8 · Reviews and meta-analyses
- Clinical outcomes of bivalirudin and heparin in pediatric extracorporeal membrane oxygenation: A systematic review and meta-analysis.
The International journal of artificial organs · September 16, 2026 · Review · cited 0 times · open access
PMID 42746993 · DOI 10.1177/03913988261481295 · Reviews and meta-analyses
- Real-world outcomes of unfractionated heparin plus antithrombin concentrate versus bivalirudin in adult patients undergoing extracorporeal membrane oxygenation.
The journal of extra-corporeal technology · September 15, 2026 · Observational human study · cited 0 times · open access
PMID 42743424 · DOI 10.1051/ject/2026015 · Human clinical research
- Comparison of bivalirudin versus heparin in percutaneous coronary intervention for patients with acute coronary syndrome: A meta-analysis.
Medicine · September 1, 2026 · Meta-analysis · cited 0 times · open access
PMID 42798052 · DOI 10.1097/md.0000000000050046 · Reviews and meta-analyses
- Bivalirudin in Primary PCI: Time to Implement the Overwhelming Evidence?
Journal of the American College of Cardiology · August 28, 2026 · Editorial, letter or other · cited 0 times · open access
PMID 42663361 · DOI 10.1016/j.jacc.2026.07.012 · Commentary and other
- Bivalirudin Versus Heparin in Low and Non-Low Bleeding Risk Patients Undergoing Primary PCI for STEMI: The BRIGHT-4 Trial.
Journal of the American College of Cardiology · August 28, 2026 · Randomized controlled trial · cited 1 times
PMID 42663356 · DOI 10.1016/j.jacc.2026.06.035 · Human clinical research
How this is counted
PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology
Search terms: Angiomax; Bivalirudin; Hirulog
((TITLE_ABS:"Angiomax" OR CHEM:"Angiomax") OR (TITLE_ABS:"Bivalirudin" OR CHEM:"Bivalirudin") OR (TITLE_ABS:"Hirulog" OR CHEM:"Hirulog")) AND SRC:MED
Cite this page
Peptide Library. (2026, November 16). Bivalirudin research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/bivalirudin